Merit Medical Systems, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US5898891040
USD
61.63
1.19 (1.97%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
382.39
394.18
384.26
381.95
354.33
354.57
339.14
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
382.39
394.18
384.26
381.95
354.33
354.57
339.14
Raw Material Cost
198.00
198.74
197.75
197.73
182.80
181.16
182.56
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
6.53
6.36
6.75
6.78
6.57
7.99
7.76
Selling and Distribution Expenses
118.21
114.83
119.80
113.10
98.29
107.97
99.64
Other Expenses
1.61
2.02
1.72
1.76
1.59
1.72
1.28
Total Expenditure (Excl Depreciation)
338.81
340.11
341.51
335.20
303.56
314.33
302.74
Operating Profit (PBDIT) excl Other Income
43.6
54.1
42.699999999999996
46.8
50.8
40.199999999999996
36.4
Other Income
18.00
3.69
3.31
2.20
4.14
1.60
10.24
Operating Profit (PBDIT)
94.93
92.09
80.30
82.76
87.18
73.43
76.02
Interest
6.53
6.36
6.75
6.78
6.57
7.99
7.76
Exceptional Items
-1.51
-0.34
-0.76
1.20
-10.38
-0.69
-2.23
Gross Profit (PBDT)
184.40
195.45
186.52
184.22
171.53
173.40
156.57
Depreciation
33.35
34.33
34.24
33.80
32.28
31.60
29.38
Profit Before Tax
53.55
51.06
38.54
43.38
37.96
33.15
36.66
Tax
12.55
13.05
10.79
10.80
7.81
5.20
8.21
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
40.99
38.01
27.75
32.58
30.15
27.95
28.44
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
40.99
38.01
27.75
32.58
30.15
27.95
28.44
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
40.99
38.01
27.75
32.58
30.15
27.95
28.44
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
1,626.73
1,584.30
1,529.41
1,488.05
1,428.42
1,379.36
1,323.41
Earnings per share (EPS)
0.68
0.63
0.46
0.54
0.49
0.46
0.48
Diluted Earnings per share
0.68
0.63
0.46
0.54
0.49
0.46
0.48
Operating Profit Margin (Excl OI)
11.4%
13.72%
11.13%
12.24%
14.33%
11.35%
10.73%
Gross Profit Margin
22.72%
21.66%
18.94%
20.21%
19.82%
18.26%
19.47%
PAT Margin
10.72%
9.64%
7.22%
8.53%
8.51%
7.88%
8.39%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Mar 2026 is -2.99% vs 2.58% in Dec 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Mar 2026 is 7.89% vs 36.69% in Dec 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is -13.01% vs 14.81% in Dec 2025

stock-summary

Interest

QoQ Growth in quarter ended Mar 2026 is 1.56% vs -5.88% in Dec 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

Compare Quarterly Results Of Merit Medical Systems, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
382.39
303.44
78.95
26.02%
Other Operating Income
0.00
0.00
0.00
Total Operating income
382.39
303.44
78.95
26.02%
Raw Material Cost
198.00
140.54
57.46
40.89%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
6.53
33.47
-26.94
-80.49%
Selling and Distribution Expenses
118.21
48.31
69.90
144.69%
Other Expenses
1.61
-3.35
4.96
148.06%
Total Expenditure (Excl Depreciation)
338.81
188.86
149.95
79.40%
Operating Profit (PBDIT) excl Other Income
43.58
114.59
-71.01
-61.97%
Other Income
18.00
-1.47
19.47
1,324.49%
Operating Profit (PBDIT)
94.93
146.15
-51.22
-35.05%
Interest
6.53
33.47
-26.94
-80.49%
Exceptional Items
-1.51
-9.15
7.64
83.50%
Gross Profit (PBDT)
184.40
162.90
21.50
13.20%
Depreciation
33.35
33.04
0.31
0.94%
Profit Before Tax
53.55
70.50
-16.95
-24.04%
Tax
12.55
35.65
-23.10
-64.80%
Provisions and contingencies
0
0
0.00
Profit After Tax
40.99
34.85
6.14
17.62%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
40.99
34.85
6.14
17.62%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
40.99
34.85
6.14
17.62%
Equity Capital
0
0
0.00
Face Value
0.00
0.01
0.00
Reserves
1,626.73
606.03
1,020.70
168.42%
Earnings per share (EPS)
0.68
0.12
0.56
466.67%
Diluted Earnings per share
0.68
0.12
0.56
466.67%
Operating Profit Margin (Excl OI)
11.40%
37.76%
0.00
-26.36%
Gross Profit Margin
22.72%
34.12%
0.00
-11.40%
PAT Margin
10.72%
11.48%
0.00
-0.76%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 38.24 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -2.99% vs 2.58% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 7.93% vs 9.66% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 4.10 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 7.89% vs 36.69% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 36.21% vs 6.74% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 7.69 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -13.01% vs 14.81% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -7.35% vs 34.52% in Mar 2025

Quarterly - Interest
Interest 0.65 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 1.56% vs -5.88% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -1.52% vs -24.14% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 11.40%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025